Digirad Corporation to Release Second Quarter and Six-Month Financial Results on July 24, 2008

Wednesday, July 16, 2008 General News J E 4
POWAY, Calif., July 15 Digirad Corporation(Nasdaq: DRAD), a leading provider of diagnostic imaging systems and servicesto physicians' offices, hospitals and other medical services providers, willrelease before the market opens on Thursday, July 24, 2008, financial resultsfor the second quarter and six months ended June 30, 2008.

A conference call is scheduled for 11:00 a.m. EDT on July 24 to discussthe results and management's outlook. A simultaneous webcast of the call maybe accessed online from the Events & Presentations link on the InvestorRelations page at; an archived replay of the webcastwill be available within 15 minutes of the end of the conference call.

About Digirad

Digirad provides diagnostic medical imaging products and services tophysicians' offices, hospitals and imaging centers for cardiac, vascular, andgeneral imaging applications. Digirad's Cardius XPO line of nuclear imagingcameras use patented solid-state technology and unique multi (single, dual,triple) head design for superior performance and advanced features for sharperdigital images, faster processing, compact size, lighter weight forportability, ability to handle patients up to 500 pounds, and improved patientcomfort compared to standard nuclear cameras. Digirad's 2020tc general-purposenuclear imager has a small footprint and may also be configured for fixed ormobile use to supplement primary imaging. Digirad's installed base ofequipment exceeds 500 systems; in addition, a mobile fleet of more than 140nuclear and ultrasound imaging systems is being used in 22 states, primarilyin the eastern, midwestern and southwestern United States. For moreinformation, please visit Digirad(R), Digirad ImagingSolutions(R), and Cardius(R) are registered trademarks of Digirad Corporation.Investor Contact: Company Contact: Dan Matsui Todd Clyde Allen & Caron CFO 949-474-4300 858-726-1600

SOURCE Digirad Corporation


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
House Passes Resolution to Recognize Cystic Fibros...
HTH Worldwide's TravelGap(R) Travel Health Insuran...